GlassScriptPhysician profile
Barbara A Pacholec
NPI 1073696902
$983.46
in general payments reported to CMS, 2019-2025
9 companies · $33.40 in 2025
The $33.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.04 · 2020: $59.65 · 2021: $103 · 2022: $550 · 2023: $185 · 2024: $40.89 · 2025: $33.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $135 · Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $134.50 |
| Food and Beverage | $124.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $469.82 | 2020-2023 | |
| Lilly USA, LLC | $197.86 | 2019-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $137.28 | 2021-2025 | Wegovy |
| Abbvie INC. | $46.00 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.02 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $33.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.55 | 2020-2022 | |
| Bausch Health US, LLC | $19.29 | 2020 | |
| Therapeuticsmd, INC. | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Pacholec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.